Metabolism - Clinical and Experimental
Volume 47, Issue 2 , Pages 149-153, February 1998

The actions of a novel lipoprotein lipase activator, NO-1886, in hypertriglyceridemic fructose-fed rats☆

  • Tsutomu Hara

      Affiliations

    • Department of Endocrinology, Royal Prince Alfred Hospital, Camperdown, Department of Biomedical Science, University of Wollongong, Wollongong, New South Wales, Australia
    • First Department of Internal Medicine, Aichi Medical University, Nagoya, Japan
    • Nutrition Research Institute, Otsuka Pharmaceutical, Tokushima, Japan
    • ,
  • David Cameron-Smith

      Affiliations

    • Corresponding Author InformationAddress reprint requests to David Cameron-Smith, PhD, School of Nutrition and Public Health, Deakin University, Burwood Campus, 221 Burwood Highway, Burwood, VIC 3125, Australia.
    • Department of Endocrinology, Royal Prince Alfred Hospital, Camperdown, Department of Biomedical Science, University of Wollongong, Wollongong, New South Wales, Australia
    • First Department of Internal Medicine, Aichi Medical University, Nagoya, Japan
    • Nutrition Research Institute, Otsuka Pharmaceutical, Tokushima, Japan
    • ,
  • Gregory J. Cooney

      Affiliations

    • Department of Endocrinology, Royal Prince Alfred Hospital, Camperdown, Department of Biomedical Science, University of Wollongong, Wollongong, New South Wales, Australia
    • First Department of Internal Medicine, Aichi Medical University, Nagoya, Japan
    • Nutrition Research Institute, Otsuka Pharmaceutical, Tokushima, Japan
    • ,
  • Masataka Kusunoki

      Affiliations

    • Department of Endocrinology, Royal Prince Alfred Hospital, Camperdown, Department of Biomedical Science, University of Wollongong, Wollongong, New South Wales, Australia
    • First Department of Internal Medicine, Aichi Medical University, Nagoya, Japan
    • Nutrition Research Institute, Otsuka Pharmaceutical, Tokushima, Japan
    • ,
  • Kazuhiko Tsutsumi

      Affiliations

    • Department of Endocrinology, Royal Prince Alfred Hospital, Camperdown, Department of Biomedical Science, University of Wollongong, Wollongong, New South Wales, Australia
    • First Department of Internal Medicine, Aichi Medical University, Nagoya, Japan
    • Nutrition Research Institute, Otsuka Pharmaceutical, Tokushima, Japan
    • ,
  • Leonard H. Storlien

      Affiliations

    • Department of Endocrinology, Royal Prince Alfred Hospital, Camperdown, Department of Biomedical Science, University of Wollongong, Wollongong, New South Wales, Australia
    • First Department of Internal Medicine, Aichi Medical University, Nagoya, Japan
    • Nutrition Research Institute, Otsuka Pharmaceutical, Tokushima, Japan

Received 9 January 1997; accepted 12 August 1997.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by project grants from National Health and Medical Research Council and a grant from the Department of Endocrinology, Royal Prince Alfred Hospital, Camperdown, Australia.

PII: S0026-0495(98)90211-6

Metabolism - Clinical and Experimental
Volume 47, Issue 2 , Pages 149-153, February 1998

Article Tools